Delayed financials from WELL Health mean an opportunity for investors, says Ventum Capital Markets analyst Rob Goff.

Ahead of the company’s fourth quarter results, CIBC analyst Todd Coupland has maintained his “Buy” rating and $7.00 price ...

Following the company’s fourth quarter results, ATB Capital analyst Martin Toner has cut his price target on Bitfarms.

Its fourth quarter results are in the books and Ventum Capital Markets analyst Andrew Semple thinks there is still good money ...

Following the company’s fourth quarter results, Citi analyst Vikram Bagri has cut his price target on Canadian Solar.

Following the company’s fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has maintained his “Buy” rating on ...

Following the company’s fourth quarter results, Beacon analyst Russell Stanley has cut his price target on Cematrix.

RBC analyst Paul Treiber thinks there is money to be made on Lumine Group. The analyst gave the stock a $50.00 target.

Following the company’s fourth quarter results, Roth analyst Suji Desilva has maintained his “Buy” rating on Intuitive ...

The stock is already a Canadian success story, but Raymond James analyst Michael W. freeman thinks there is still money to be ...

With less visibility on its financial outlook, RBC analyst Daniel Perlin has cut his price target on Lightspeed Commerce.

Following the company’s fourth quarter results, Haywood analyst Neal Gilmer has cut his price target on East Side Games.